• Live-Dead Cell Staining Kit: Precision Viability for Advance

  2026-05-29

  The Live-Dead Cell Staining Kit from APExBIO enables rapid, dual-dye quantification of viable and non-viable cells for robust viability, cytotoxicity, and biomaterial testing. This article unpacks experimental best practices, troubleshooting, and data-driven advantages compared to conventional assays.

• Gap26 Connexin 43 Mimetic Peptide: Precision in Calcium Sign

  2026-05-28

  Gap26 empowers researchers to dissect connexin 43 function with high specificity, enabling reproducible modulation of intercellular calcium and ATP signaling. This guide delivers actionable protocols and troubleshooting strategies for maximizing the translational impact of Gap26 in vascular, neurobiological, and inflammatory assay systems.

• Z-VDVAD-FMK: Advanced Caspase Inhibition in Apoptosis Assays

  2026-05-28

  Z-VDVAD-FMK, also known as benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone, sets a new standard for dissecting caspase-2-dependent apoptosis and mitochondrial signaling. Its protocol-optimized solubility, selectivity, and workflow reliability make it indispensable for researchers seeking reproducible, mechanistically validated results in apoptosis, cancer, and virology studies.

• Pleiotrophin’s Role in BPH: Regulation of Proliferation and

  2026-05-27

  Liu et al. reveal that pleiotrophin (PTN) is a key modulator of cell proliferation, smooth muscle contraction, and fibrosis in benign prostatic hyperplasia (BPH). Through integrated in vitro and in vivo models, they identify the AKT and RhoA/ROCK pathways as central PTN effectors, highlighting PTN as a promising therapeutic target for BPH intervention.

• Z-WEHD-FMK: Advancing Caspase Pathway Analysis in Inflammati

  2026-05-27

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) stands out for its robust, irreversible inhibition of key inflammatory caspases in cell biology and infectious disease research. This guide delivers actionable protocols, troubleshooting strategies, and cross-study insights to help researchers unlock reproducible results in apoptosis and inflammation assays.

• EPO-Modified MSCs Enhance Mitochondrial Transfer to Alleviat

  2026-05-26

  Zhang et al. (2025) demonstrate that erythropoietin-modified bone marrow mesenchymal stem cells (EPO-BM-MSCs) significantly alleviate airway inflammation in asthma by enhancing mitochondrial activation and transfer to epithelial cells via upregulation of HO-1. This mechanistic insight highlights a promising therapeutic avenue centered on mitochondrial transfer and intercellular communication.

• 2-APB in Precision Calcium Signaling: Translating Mechanisti

  2026-05-26

  This article explores how 2-APB (2-aminoethoxydiphenyl borate) empowers translational researchers to dissect the autophagy–apoptosis axis via ER-Ca2+-calpain signaling. By integrating new mechanistic findings from Bombyx mori, competitive benchmarking, and actionable protocol guidance, we provide a strategic roadmap for leveraging APExBIO's 2-APB in advanced cell fate research.

• Prestained Protein Marker: Triple Color Workflow Optimizatio

  2026-05-25

  Elevate your protein analysis with the Triple color Prestained Protein Marker—offering immediate visual clarity, broad compatibility, and robust performance in SDS-PAGE and Western blotting. Discover advanced workflow strategies and troubleshooting insights that set APExBIO's marker apart for high-impact, reproducible results.

• Hepatic sEH Suppression of Nrf2 in Osteoclastogenesis and Os

  2026-05-25

  This study uncovers a liver-bone communication axis in osteoporosis, identifying hepatic soluble epoxide hydrolase (sEH) as a regulator of osteoclast differentiation through suppression of the Nrf2 signaling pathway. The findings provide mechanistic insight into redox imbalance and suggest new avenues for targeted biochemical research.

• Pharmacology and Differentiation of ACE Inhibitors: Focus on

  2026-05-24

  This article reviews the seminal overview of angiotensin-converting enzyme (ACE) inhibitors, emphasizing how structural and pharmacokinetic diversity among agents, notably Fosinopril sodium, shapes antihypertensive efficacy and safety. The findings clarify critical considerations for cardiovascular and hypertension research models, highlighting the value of phosphinic acid ACE inhibitors for translational workflows.

• CBX2-Driven Immune Evasion in Cancer: Noncanonical Epigeneti

  2026-05-23

  A recent study elucidates how CBX2, a polycomb group protein, suppresses tumor immunogenicity by forming a noncanonical complex that attenuates interferon signaling, independent of traditional PRC2 activity. These findings highlight a novel epigenetic mechanism of immune evasion, with implications for the development of innovative cancer immunotherapies.

• Ziprasidone Augmentation in Anxious Depression: Insights and

  2026-05-22

  This article examines a pivotal study assessing ziprasidone augmentation of escitalopram in patients with anxious versus nonanxious depression. The findings clarify the nuanced efficacy of adjunctive antipsychotic therapy in mood and anxiety symptom domains, with important implications for translational antidepressant research.

• Biotin Azide: Precision Biotinylation for Click Chemistry Wo

  2026-05-22

  Biotin Azide from APExBIO empowers researchers to achieve highly selective and efficient biotin labeling of alkynylated biomolecules, streamlining affinity purification and detection with minimal biological perturbation. Explore advanced workflows, troubleshooting strategies, and practical insights that set this reagent apart in the context of complex biological signaling studies.

• ABT-263 (Navitoclax): Advanced Workflows in Apoptosis Assays

  2026-05-21

  ABT-263 (Navitoclax) is redefining apoptosis research, enabling precise targeting of Bcl-2 family proteins and offering powerful tools for dissecting chemoresistance in cancer models. This article distills robust experimental workflows, troubleshooting strategies, and advanced applications to maximize the impact of ABT-263 in oncology and senescence studies.

• Pleuromutilin-Ribosome Interactions and Resistance Mechanism

  2026-05-21

  This article discusses how pleuromutilin antibiotics, including tiamulin and valnemulin, interact with the ribosomal peptidyl transferase center. The reference study reveals structural determinants of resistance and provides insights for designing improved derivatives, with practical implications for antibiotic development and nucleic acid probe applications.

499 records 13/34 page Previous Next First page 上5页 1112131415 下5页 Last page